{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:09:06Z","timestamp":1782238146639,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"am","delay-in-days":414,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103424-21"],"award-info":[{"award-number":["P20GM103424-21"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006952","name":"Louisiana Board of Regents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006952","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ghir.2023.101534","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:09:54Z","timestamp":1684411794000},"page":"101534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Growth hormone-releasing hormone antagonists counteract hydrogen peroxide \u2013 induced paracellular hyperpermeability in endothelial cells"],"prefix":"10.1016","volume":"69-70","author":[{"given":"Nektarios","family":"Barabutis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Siejka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2023.101534_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170716","article-title":"Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity","volume":"150","author":"Cai","year":"2022","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.ghir.2023.101534_bb0010","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1210\/en.2019-00111","article-title":"Actions and potential therapeutic applications of growth hormone-releasing hormone agonists","volume":"160","author":"Schally","year":"2019","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ghir.2023.101534_bb0015","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1073\/pnas.97.3.1218","article-title":"Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro","volume":"97","author":"Rekasi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ghir.2023.101534_bb0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pros.2990140302","article-title":"Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia","volume":"14","author":"Fekete","year":"1989","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.ghir.2023.101534_bb0025","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac209","article-title":"Growth hormone-releasing hormone in endothelial inflammation","volume":"164","author":"Barabutis","year":"2022","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ghir.2023.101534_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151233","article-title":"Molecular mechanisms underlying the heterogeneous barrier responses of two primary endothelial cell types to sphingosine-1-phosphate","volume":"101","author":"Salminen","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ghir.2023.101534_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109699","article-title":"Unfolded protein response in cardiovascular disease","volume":"73","author":"Kubra","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ghir.2023.101534_bb0040","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fmed.2020.00344","article-title":"Unfolded protein response in lung health and disease","volume":"7","author":"Barabutis","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.ghir.2023.101534_bb0045","doi-asserted-by":"crossref","first-page":"100373","DOI":"10.1016\/j.coesh.2022.100373","article-title":"The Covid19 pandemic: virus transmission and risk assessment","volume":"28","author":"Menon","year":"2022","journal-title":"Curr. Opin. Environ. Sci. Health"},{"issue":"4","key":"10.1016\/j.ghir.2023.101534_bb0050","doi-asserted-by":"crossref","first-page":"1669989","DOI":"10.1080\/21688370.2019.1669989","article-title":"GHRH antagonists support lung endothelial barrier function","volume":"7","author":"Uddin","year":"2019","journal-title":"Tissue Barrier."},{"issue":"2","key":"10.1016\/j.ghir.2023.101534_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00011-021-01531-5","article-title":"An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration","volume":"71","author":"Akhter","year":"2022","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.ghir.2023.101534_bb0060","first-page":"L419","article-title":"Mechanisms regulating endothelial cell barrier function","volume":"279","author":"Stevens","year":"2000","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"12","key":"10.1016\/j.ghir.2023.101534_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010533","article-title":"Actin remodeling mediates ROS production and JNK activation to drive apoptosis-induced proliferation","volume":"18","author":"Farrell","year":"2022","journal-title":"PLoS Genet."},{"issue":"7","key":"10.1016\/j.ghir.2023.101534_bb0070","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.ghir.2023.101534_bb0075","first-page":"114","article-title":"Vascular hyperpermeability and aging","volume":"5","author":"Oakley","year":"2014","journal-title":"Aging Dis."},{"key":"10.1016\/j.ghir.2023.101534_bb0080","first-page":"1","article-title":"Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption","author":"Akhter","year":"2022","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.ghir.2023.101534_bb0085","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/pros.21142","article-title":"Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells","volume":"70","author":"Siejka","year":"2010","journal-title":"Prostate"},{"issue":"9","key":"10.1016\/j.ghir.2023.101534_bb0090","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/j.1464-410X.2010.09215.x","article-title":"Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix","volume":"106","author":"Siejka","year":"2010","journal-title":"BJU Int."},{"issue":"10","key":"10.1016\/j.ghir.2023.101534_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22879","article-title":"Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone-releasing hormone","volume":"35","author":"Akhter","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.ghir.2023.101534_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ncpendmet0677","article-title":"Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer","volume":"4","author":"Schally","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2023.101534_bb0105","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1582-4934.2010.01096.x","article-title":"Growth hormone releasing hormone induces the expression of nitric oxide synthase","volume":"15","author":"Barabutis","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ghir.2023.101534_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fphys.2016.00206","article-title":"Neuronal nitric oxide synthase in vascular physiology and diseases","volume":"7","author":"Costa","year":"2016","journal-title":"Front. Physiol."},{"issue":"51","key":"10.1016\/j.ghir.2023.101534_bb0115","doi-asserted-by":"crossref","first-page":"20470","DOI":"10.1073\/pnas.0811209106","article-title":"Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line","volume":"105","author":"Barabutis","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ghir.2023.101534_bb0120","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/endocrines3040067","article-title":"Growth hormone-releasing hormone antagonist JV-1-36 suppresses reactive oxygen species generation in A549 lung Cancer cells","volume":"3","author":"Kubra","year":"2022","journal-title":"Endocrines"},{"issue":"8","key":"10.1016\/j.ghir.2023.101534_bb0125","first-page":"L776","article-title":"p53 protects against LPS-induced lung endothelial barrier dysfunction","volume":"308","author":"Barabutis","year":"2015","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"12","key":"10.1016\/j.ghir.2023.101534_bb0130","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00262-008-0639-6","article-title":"Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53","volume":"58","author":"Salvioli","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.ghir.2023.101534_bb0135","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jcmm.13460","article-title":"Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition","volume":"22","author":"Barabutis","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.ghir.2023.101534_bb0140","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s10753-019-01150-7","article-title":"P53 regulates the redox status of lung endothelial cells","volume":"43","author":"Akhter","year":"2020","journal-title":"Inflammation"},{"issue":"5\u20136","key":"10.1016\/j.ghir.2023.101534_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cm.21604","article-title":"P53 in RhoA regulation","volume":"77","author":"Barabutis","year":"2020","journal-title":"Cytoskeleton (Hoboken)"},{"issue":"4","key":"10.1016\/j.ghir.2023.101534_bb0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/21541248.2016.1224399","article-title":"Rac1 and RhoA: networks, loops and bistability","volume":"9","author":"Nguyen","year":"2018","journal-title":"Small GTPases"},{"key":"10.1016\/j.ghir.2023.101534_bb0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.crphys.2020.07.001","article-title":"P53 deficiency potentiates LPS-induced acute lung injury in vivo","volume":"3","author":"Uddin","year":"2020","journal-title":"Curr. Res. Physiol."},{"issue":"22","key":"10.1016\/j.ghir.2023.101534_bb0160","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1093\/emboj\/cdf595","article-title":"\u201csuper p53\u201d mice exhibit enhanced DNA damage response, are tumor resistant and age normally","volume":"21","author":"Garcia-Cao","year":"2002","journal-title":"EMBO J."},{"issue":"22","key":"10.1016\/j.ghir.2023.101534_bb0165","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1007\/s00018-020-03629-1","article-title":"P53 in acute respiratory distress syndrome","volume":"77","author":"Barabutis","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.ghir.2023.101534_bb0170","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/iub.2251","article-title":"Regulation of lung endothelial permeability by NEK kinases","volume":"72","author":"Barabutis","year":"2020","journal-title":"IUBMB Life"},{"issue":"4","key":"10.1016\/j.ghir.2023.101534_bb0175","doi-asserted-by":"crossref","first-page":"1929787","DOI":"10.1080\/21688370.2021.1929787","article-title":"Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis","volume":"9","author":"Uddin","year":"2021","journal-title":"Tissue Barrier."},{"key":"10.1016\/j.ghir.2023.101534_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109500","article-title":"Hsp90 inhibitors induce the unfolded protein response in bovine and mice lung cells","volume":"67","author":"Kubra","year":"2020","journal-title":"Cell. Signal."},{"issue":"19","key":"10.1016\/j.ghir.2023.101534_bb0185","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1080\/15384101.2022.2082024","article-title":"Unfolded protein response in endothelial injury","volume":"21","author":"Barabutis","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ghir.2023.101534_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110432","article-title":"Activating transcription factor 6 protects against endothelial barrier dysfunction","volume":"99","author":"Kubra","year":"2022","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.ghir.2023.101534_bb0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12079-020-00593-0","article-title":"Involvement of the unfolded protein response in the protective effects of growth hormone releasing hormone antagonists in the lungs","volume":"15","author":"Akhter","year":"2021","journal-title":"J. Cell Commun. Sign."},{"issue":"1","key":"10.1016\/j.ghir.2023.101534_bb0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-018-08129-2","article-title":"Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis","volume":"10","author":"Blackwood","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637423000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637423000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:59Z","timestamp":1761087179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637423000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"alternative-id":["S1096637423000126"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2023.101534","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone-releasing hormone antagonists counteract hydrogen peroxide \u2013 induced paracellular hyperpermeability in endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2023.101534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101534"}}